Human cytomegalovirus infection leads to elevated levels of transplant arteriosclerosis in a humanized mouse aortic xenograft model

scientific article published on 19 March 2012

Human cytomegalovirus infection leads to elevated levels of transplant arteriosclerosis in a humanized mouse aortic xenograft model is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1600-6143.2012.04018.X
P698PubMed publication ID22429329
P5875ResearchGate publication ID221722010

P50authorChristian HeimQ43002929
P2093author name stringR Müller
J Hoffmann
T Stamminger
M Weyand
B M Spriewald
M Leis
M Wollin
S M Ensminger
S Abele-Ohl
S Mahmoudian
P2860cites workHCMV-infection in a human arterial organ culture model: effects on cell proliferation and neointimal hyperplasiaQ33292028
Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3bQ33799527
Coronary artery disease in the transplanted heartQ33895982
Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allograftsQ34169756
The human cytomegalovirus ribonucleotide reductase homolog UL45 is dispensable for growth in endothelial cells, as determined by a BAC-cloned clinical isolate of human cytomegalovirus with preserved wild-type characteristicsQ34345137
Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplantsQ34467148
Cytomegalovirus and transplant arteriopathy: evidence for a link is mounting, but the jury is still out.Q35096458
Immunopathology of human T cell responses to skin, artery and endothelial cell grafts in the human peripheral blood lymphocyte/severe combined immunodeficient mouseQ35211612
The role of viruses in cardiac allograft vasculopathyQ35671637
Current understanding and management of allograft vasculopathyQ36001190
Immune activation following cytomegalovirus infection: more important than direct viral effects in cardiovascular disease?Q36357628
Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and beta1 and beta3 integrinsQ36535574
Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healingQ37220021
Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infectionQ41913861
Deletion of open reading frame UL26 from the human cytomegalovirus genome results in reduced viral growth, which involves impaired stability of viral particlesQ41947389
Synergistic induction of intercellular adhesion molecule-1 by the human cytomegalovirus transactivators IE2p86 and pp71 is mediated via an Sp1-binding siteQ42049262
Murine cytomegalovirus infection leads to increased levels of transplant arteriosclerosis in a murine aortic allograft modelQ43002865
Cytomegalovirus accelerates chronic allograft nephropathy in a rat renal transplant model with associated provocative chemokine profilesQ43416695
The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and functionQ44322674
Heart and lung transplantation in the United States, 1997-2006.Q44412320
Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) miceQ45016192
Prophylaxis versus preemptive therapy for prevention of the consequences of cytomegalovirus infection in transplant recipients: a still unresolved issueQ45062894
The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migrationQ45863859
The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report--2010.Q45945360
Prophylaxis versus preemptive anti-cytomegalovirus approach for prevention of allograft vasculopathy in heart transplant recipients.Q46024867
Human cytomegalovirus infection in human renal arteries in vitroQ48001832
Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1.Q53592113
Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection.Q54587707
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectcytomegaloviral diseaseQ2076966
CytomegalovirusQ6946
xenograftQ64148587
P304page(s)1720-1729
P577publication date2012-03-19
P1433published inAmerican Journal of TransplantationQ4744273
P1476titleHuman cytomegalovirus infection leads to elevated levels of transplant arteriosclerosis in a humanized mouse aortic xenograft model
P478volume12

Reverse relations

cites work (P2860)
Q35139237A human lung xenograft mouse model of Nipah virus infection
Q34369349A method for quantifying mechanical properties of tissue following viral infection
Q34135605Generation of improved humanized mouse models for human infectious diseases
Q39329450Humanized mice: A brief overview on their diverse applications in biomedical research.
Q36142747Humanized mouse models of human cytomegalovirus infection
Q44117675Procurement regimens to reduce ischemia reperfusion injury of vascular grafts
Q43112327Viral infection at the endothelium

Search more.